Evidence map›Paper›PMID 38300320›Full record

ArticleCellular and molecular life sciences : CMLS2024

Glucosylceramide in bunyavirus particles is essential for virus binding to host cells.

Zina M Uckeley, Maëva Duboeuf, Yu Gu, Alexandra Erny, Magalie Mazelier, Christian Lüchtenborg, Sophie L Winter, Paulina Schad, Cyrille Mathieu, Jana Koch and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Zina M UckeleyCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, 69120, Heidelberg, Germany.
Maëva DuboeufUniversité Claude Bernard Lyon 1, INRAE, EPHE, IVPC UMR754, Team iWays, 69007, Lyon, France.
Yu GuUniversité Claude Bernard Lyon 1, INRAE, EPHE, IVPC UMR754, Team iWays, 69007, Lyon, France.
Alexandra ErnyUniversité Claude Bernard Lyon 1, INRAE, EPHE, IVPC UMR754, Team iWays, 69007, Lyon, France.
Magalie MazelierCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, 69120, Heidelberg, Germany.
Christian LüchtenborgHeidelberg University Biochemistry Center (BZH), Heidelberg, Germany.
Sophie L WinterCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, 69120, Heidelberg, Germany.
Paulina SchadCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, 69120, Heidelberg, Germany.
Cyrille MathieuCIRI (Centre International de Recherche en Infectiologie), Team Neuro-Invasion, TROpism and VIRal Encephalitis, INSERM U1111, CNRS UMR5308, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, 69007, Lyon, France.
Jana KochCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, 69120, Heidelberg, Germany.
Steeve BoulantDepartment for Molecular Genetics and Microbiology, University of Florida, Gainesville, USA.
Petr ChlandaCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, 69120, Heidelberg, Germany.
Carine MaisseUniversité Claude Bernard Lyon 1, INRAE, EPHE, IVPC UMR754, Team iWays, 69007, Lyon, France.
Britta BrüggerHeidelberg University Biochemistry Center (BZH), Heidelberg, Germany.
Pierre-Yves LozachCenter for Integrative Infectious Diseases Research (CIID), University Hospital Heidelberg, 69120, Heidelberg, Germany. pierre-yves.lozach@inrae.fr.ORCID http://orcid.org/0000-0002-9966-1452
Heidelberg University · DEUniversité Claude Bernard Lyon 1 · FRUniversity of Florida · US

Funding

Agence Nationale de la Recherche ANR-21-CE11-0012Agence Nationale de la Recherche ANR-22-CE15-0034Chinese Scholarship Council 202106790021Deutsche Forschungsgemeinschaft INST 35/1314-1 FUGGDeutsche Forschungsgemeinschaft INST 35/1503-1 FUGGDeutsche Forschungsgemeinschaft LO-2338/1-1Deutsche Forschungsgemeinschaft LO-2338/3-1Fondation Innovations en Infectiologie AO14INRAE Starter funds
6 · The paper itself

Abstract

Hexosylceramides (HexCer) are implicated in the infection process of various pathogens. However, the molecular and cellular functions of HexCer in infectious cycles are poorly understood. Investigating the enveloped virus Uukuniemi (UUKV), a bunyavirus of the Phenuiviridae family, we performed a lipidomic analysis with mass spectrometry and determined the lipidome of both infected cells and derived virions. We found that UUKV alters the processing of HexCer to glycosphingolipids (GSL) in infected cells. The infection resulted in the overexpression of glucosylceramide (GlcCer) synthase (UGCG) and the specific accumulation of GlcCer and its subsequent incorporation into viral progeny. UUKV and several pathogenic bunyaviruses relied on GlcCer in the viral envelope for binding to various host cell types. Overall, our results indicate that GlcCer is a structural determinant of virions crucial for bunyavirus infectivity. This study also highlights the importance of glycolipids on virions in facilitating interactions with host cell receptors and infectious entry of enveloped viruses.

Indexed as

OrthobunyavirusGlucosylceramidesLipidomicsMass SpectrometryVirus AttachmentGlucosylceramidesAlphavirusGlucosylceramide synthaseLipidomicsUGCGVirus–receptor interactions

Identifiers

PMID38300320
PMCPMC10834583
OpenAlexW4391446420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.